Eastman Kodak Company — KODK
| Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
|---|---|---|---|---|---|---|---|
| $7.32 | $705.65M | - | - | N/A | - | - | 0.9 |
Latest Headlines
- · Renowned Filmmaker and Creative Director Dr. Bob Gordon Joins Immorta Bio Strategic Advisory Board
- · Those who invested in Eastman Kodak (NYSE:KODK) three years ago are up 117%
- · Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products
- · Reju Announces Site of First Commercial-Scale US Factory
- · Eastman Kodak (NYSE:KODK) Is Experiencing Growth In Returns On Capital
- · Why I Won't Touch the Sell Button on Alphabet Stock
Revenue & Net Income
| Date | Revenue | Net_Income | EPS | Last_Updated | Revenue_Change | Net_Income_Change | EPS_Change | |
|---|---|---|---|---|---|---|---|---|
| 0 | 2020-12-31 | $1,029M | $-541M | $-9.77 | 2024-05-16 02:26:54 | N/A | N/A | N/A |
| 1 | 2021-12-31 | $1,150M | $24M | $0.30 | 2026-02-27 22:00:27 | 11.8% | -104.4% | -103.1% |
| 2 | 2022-12-31 | $1,205M | $26M | $0.33 | 2026-02-27 22:00:27 | 4.8% | 8.3% | 7.8% |
| 3 | 2023-12-31 | $1,117M | $75M | $0.71 | 2026-02-27 22:00:27 | -7.3% | 188.5% | 116.0% |
| 4 | 2024-12-31 | $1,043M | $102M | $0.97 | 2026-02-27 22:00:27 | -6.6% | 36.0% | 36.6% |
| 5 | TTM 2025-09-30 | $1,045M | $6M | $-0.32 | 2026-02-05 08:32:46 | 0.2% | -94.1% | -133.0% |
EPS
Forecasts
Y/Y % Change
No data available
Expenses
| Year | Revenue ($) | Cost of Revenue ($) | R&D ($) | SG&A ($) | Facilities / D&A ($) |
|---|---|---|---|---|---|
| 2021 | $1.1B | $955.0M | $33.0M | $177.0M | $31.0M |
| 2022 | $1.2B | $1.0B | $34.0M | $153.0M | $29.0M |
| 2023 | $1.1B | $877.0M | $34.0M | $159.0M | $30.0M |
| 2024 | $1.0B | $812.0M | $33.0M | $179.0M | $28.0M |
| TTM | $1.0B | $801.0M | $33.0M | $170.0M | $28.0M |
| Year | Revenue Change (%) | Cost of Revenue Change (%) | R&D Change (%) | SG&A Change (%) | Facilities / D&A Change (%) |
|---|---|---|---|---|---|
| 2022 | 4.78 | 5.34 | 3.03 | -13.56 | -6.45 |
| 2023 | -7.30 | -12.82 | 0.00 | 3.92 | 3.45 |
| 2024 | -6.62 | -7.41 | -2.94 | 12.58 | -6.67 |
| TTM | 0.19 | -1.35 | 0.00 | -5.03 | 0.00 |
No unmapped expenses.
Balance Sheet
| Metric | Value | |
|---|---|---|
| 0 | Total Assets | $2,075M |
| 1 | Cash | $168M |
| 2 | Total Liabilities | $1,214M |
| 3 | Total Debt | $549M |
| 4 | Total Equity | $861M |
| 5 | Debt to Equity Ratio | 0.64 |
EPS & Dividend
Valuation
No data available
No data available
Implied Growth
| Average | Median | Std Dev | Current | Percentile | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | |
| Timeframe | ||||||||||
| 1 Year | 7.39% | – | 7.68% | – | 0.79% | – | 5.53% | – | 2.4% | – |
| 3 Years | 7.39% | – | 7.68% | – | 0.79% | – | 5.53% | – | 2.4% | – |
| 5 Years | 7.39% | – | 7.68% | – | 0.79% | – | 5.53% | – | 2.4% | – |
| 10 Years | 7.39% | – | 7.68% | – | 0.79% | – | 5.53% | – | 2.4% | – |